Skip to main content
Fig. 4 | BMC Veterinary Research

Fig. 4

From: A novel strategy for developing vaccine candidate against Jaagsiekte sheep retrovirus from the envelope and gag proteins: an in-silico approach

Fig. 4

a As compared to E. coli, the vaccine was soluble, with a predicted scaled solubility of 0.621 versus 0.45 of the E. coli solubility based on the population averages. b Engineering disulfide bonds to stabilize vaccine constructs showing the wild-type version. c The mutant version showed six disulfide bonds added in regions of golden sticky forms indicated by white arrows

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us